Brief: Keros Therapeutics Q3 EPS USD -1.41
06/11/2024 21:01
Nov 06 (Reuters) - Keros Therapeutics Q3 net income USD -52.956 million
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops